资讯

MorningStar Laboratories, LLC., (“MSL” or “the Company”), is a leading developer of precision diagnostic tests that address unmet clinical needs, is proud to announce its expansion in the Midwest with ...
Researchers develop an AI model that uses ECG data to predict the risk for adverse vascular events in patients with migraine.
Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s ...
“Today marks a significant advancement in how we approach vascular and inflammatory health,” said Lawrence Dentice, President, Chief Commercial Officer & Director, MorningStar Laboratories. “The ...
New blood tests, scans, and fitness trackers that purport to predict longevity are rolling out all the time, but if you’ve ...
Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s ...
Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s vascular ...
After a rest period, participants completed an eight-minute mental math test designed to raise stress levels, during which ...
For additional information about the SmartVascular Dx test or to schedule a consultation, please contact MorningStar Laboratories at 949.267.7875 or visit .
Stellar Market Research examines the growth rate of the Vascular Access Device Market during the forecasted period 2025-2032 The Vascular Access Device Market is projected to grow at a CAGR of ...